CVS Health Corp (CVS)

CVS (NYSE:Health Services)
$100.58
neg -0.04
-0.04%
Today's Range: 100.31 - 100.59 | CVS Avg Daily Volume: 4,427,100
Last Update: 01/26/15 - 9:51 AM EST
Volume: 140,501
YTD Performance: 4.48%
Open: $100.50
Previous Close: $100.62
52 Week Range: $64.95 - $101.34
Oustanding Shares: 1,146,383,477
Market Cap: 114,959,335,074
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 14 13 14
Moderate Buy 3 3 3 3
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.34 1.34 1.45 1.42
Latest Dividend: 0.35
Latest Dividend Yield: 1.40%
Dividend Ex-Date: 01/20/15
Price Earnings Ratio: 25.91
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
25.91 25.90 26.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
20.36% 46.95% 133.89%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.90 0.31 0.09
Net Income 18.50 0.34 0.10
EPS 23.80 0.50 0.14
Earnings for CVS:
EBITDA 9.91B
Revenue 126.76B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.21 $1.08 $4.50 $5.14
Number of Analysts 12 10 14 14
High Estimate $1.24 $1.09 $4.53 $5.20
Low Estimate $1.19 $1.06 $4.48 $5.08
Prior Year $1.12 $1.02 $4.00 $4.50
Growth Rate (Year over Year) 7.59% 5.59% 12.39% 14.41%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Jan 21, 2015 | 8:34 AM EST
CVS was upgraded to Buy, Goldman Sachs said. $113 price target. Company can deliver consistent 15% annual earnings growth. 
Two analysts predicted the big rise in Netflix. Well done.
These store-based U.S. retailers are an eclectic mix.

Why I'm Sticking With Biotech Real Money Pro($)

They offer a nice shelter for the headwinds now hitting equities.

Gilead Is a Buying Opportunity Real Money Pro($)

Its hepatitis C drug is better; the stock trades at a discount.
And stop chasing stocks that won't let you in.
Let's look at the other groups that caught fire.
CVS is a healthy company trading at an unhealthy level.
Do your homework before the meeting.
Bullish
Dec 17, 2014 | 7:29 AM EST
CVS price target raised to $107 from $98, said Barclays. Stock is trading at a lower than expected multiple given multi-year EPS growth...

Columnist Conversations

Market is weathering election results from Greece quite well. After so many bailouts over the past few years,...
No rest for the weary this week as the earnings season is in full bloom. The heaviest two weeks of releases s...
The result of the Greek election looks likely to add to volatility in the euro's exchange rate to the dollar. ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.